Episode 05 - Dr Paul Peter Tak, CEO & President Candel Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. This week we welcome Paul Peter Tak! CEO and President of Candel Therapeutics From a professorship in his native Netherlands to the SVP, Chief Immunology Officer, and global development leader at GSK, and from leading small biotechs such as Tempero and Kintai to entering the venture world as a Flagship partner. Now, he is the CEO and President of Candel Therapeutics – a promising clinical immunotherapy company in the fight against cancer. Enjoy and stay tuned.

Episode metadata supplied by the publisher feed · Published Feb 14, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 05 - Dr Paul Peter Tak, CEO & President Candel Therapeutics

0:00 32:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 32 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on February 14, 2024.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!